Area of research
Psychiatry and Mental health · Physiology
Research interest
Research focused on Dementia and Biomarker, with related work in Mendelian randomization, Disease, Geriatric psychiatry. Notable publications include 'Plasma proteomic profiles predict future dementia in healthy adults', 'Atlas of the plasma proteome in health and disease in 53,026 adults', and 'FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study'.
Safety and short-term outcomes of lecanemab for Alzheimer’s disease in China: a multicentre study
Drilling mechanism of temperature‐sensitive non‐directional <scp>UHMWPE</scp> fiber composites
Plasma proteomic profiles predict future dementia in healthy adults
Atlas of the plasma proteome in health and disease in 53,026 adults
Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer’s disease
Planococcus shenhongbingii sp. nov., Planococcus shixiaomingii sp. nov. and Planococcus liqunii sp. nov., isolated from soil of the Qinghai-Tibet Plateau
Depression in Alzheimer’s Disease: Epidemiology, Mechanisms, and Treatment
Plasma Glial Fibrillary Acidic Protein in the Alzheimer Disease Continuum: Relationship to Other Biomarkers, Differential Diagnosis, and Prediction of Clinical Progression
Emergence of an ancient and pathogenic mammarenavirus
Species-level microbiota of ticks and fleas from Marmota himalayana in the Qinghai-Tibet Plateau
Description of Ornithinimicrobium cryptoxanthini sp. nov., a Novel Actinomycete Producing β-cryptoxanthin Isolated from the Tongtian River Sediments
Taxonomic descriptions of Aeromicrobium duanguangcaii sp. nov., Aeromicrobium wangtongii sp. nov. and Aeromicrobium senzhongii sp. nov.
Identifying causal genes for depression via integration of the proteome and transcriptome from brain and blood
Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study
Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood
The Threat of Potentially Pathogenic Bacteria in the Feces of Bats
Morphological and genomic characteristics of two novel halotolerant actinomycetes, Tomitella gaofuii sp. nov. and Tomitella fengzijianii sp. nov. isolated from bat faeces
Phenotypic and genomic characteristics of Brevibacterium zhoupengii sp. nov., a novel halotolerant actinomycete isolated from bat feces
Gordonia zhenghanii sp. nov. and Gordonia liuliyuniae sp. nov., isolated from bat faeces
Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis
The role of the immune system in Alzheimer’s disease
Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer’s disease: A systematic review and meta-analysis
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
Agromyces laixinhei sp. nov. isolated from bat feces in China
Gordonia jinghuaiqii sp. nov. and Gordonia zhaorongruii sp. nov., isolated from Tibetan Plateau wildlife
Identification of Haloactinobacterium kanbiaonis sp. nov. and Ruania zhangjianzhongii sp. nov., two novel species of the family Ruaniaceae isolated from faeces of bats (Hipposideros spp.)
Characterization of isolates of members of the genus Actinomyces from Marmota himalayana: description of Actinomyces faecalis sp. nov., Actinomyces respiraculi sp. nov., and Actinomyces trachealis sp. nov.
Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia